Protiva is the first and only collagen protein powder to have completed a full Institutional Review Board (IRB) approved clinical study. Find out more here.
Protiva is the only protein product to participate in an Institutional Review Board (IRB) approved multiple site, clinical study of women while they were pregnant, recovering from delivery and breastfeeding. Pregnant women who participated in the clinical study had their blood drawn to monitor protein and albumin levels. Nearly 85% of the pregnant women had initial protein levels that were either below the normal range or barely at the normal range. After taking Protiva, 100% of the women achieved normal protein levels and maintained them while they remained on Protiva. You can download a copy of the study here [[link]] – we encourage you to read and discuss it with your doctor.